Ono Pharmaceutical (OTCMKTS:OPHLF) Stock Passes Below Two Hundred Day Moving Average of $16.47

Shares of Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLF) crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $16.47 and traded as low as $12.66. Ono Pharmaceutical shares last traded at $13.45, with a volume of 612 shares trading hands.

Ono Pharmaceutical Stock Performance

The stock has a 50 day simple moving average of $14.87 and a 200-day simple moving average of $16.45.

Ono Pharmaceutical (OTCMKTS:OPHLF) last posted its quarterly earnings results on Thursday, May 9th. The company reported $0.25 earnings per share (EPS) for the quarter. Ono Pharmaceutical had a return on equity of 16.14% and a net margin of 25.52%. The firm had revenue of $759.39 million during the quarter. As a group, equities research analysts forecast that Ono Pharmaceutical Co., Ltd. will post 1.33 EPS for the current fiscal year.

About Ono Pharmaceutical

Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.